CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 601 enrolled
Drug / intervention
Radiotherapy +3 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00122772
NCT00122772Phase 3Completed
CompareCT.gov

CRP on Radiobiological and Clinical Studies on Viral-induced Cancer's Response to Radiotherapy With Comprehensive Morbidity Assessment

International Atomic Energy Agency·interventional·Posted Jul 22, 2005·Updated Oct 14, 2011

In Brief

A Phase 3 clinical trial evaluating Radiotherapy and Radiotherapy/Cisplatin for Cervix Cancer. Completed, enrolled 601 participants across 11 sites in 11 countries.

Detailed Summary

The purpose of this trial is to study clinical effects of two/four high dose rate (HDR) brachytherapy applications and teletherapy with or without weekly cisplatin in cervix cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervix Cancer
CountriesAustria, Brazil, Canada, India, Morocco, North Macedonia, Pakistan, Peru, South Africa, South Korea, United Kingdom
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 22, 2005
Enrollment StartNov 1, 2005
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 20.9 years ago

Interventions

Radiotherapyradiation

External Beam Radiation 46Gy in 23 daily fractions High Dose Brachytherapy 2 fractions of 9Gy

Radiotherapyradiation

External Beam Radiotherapy 46Gy in 23 daily fractions High Dose Brachytherapy 4 fractions of 7Gy

Radiotherapy/Cisplatinradiation

External Beam Radiation 46Gy in 23 daily fractions High Dose Brachytherapy 2 fractions of 9Gy Cisplatin 40 mg/sqm weekly

Radiotherapy/Cisplatinradiation

External Beam Radiotherapy 46Gy in 23 daily fractions High Dose Brachytherapy 4 fractions of 7Gy Cisplatin 40mg/sqm weekly